Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective.

Area of Science:

• Oncology
• Immunology
• Biochemistry

Background:

• Nitric oxide synthase 2 (NOS2) and cyclooxygenase 2 (COX2) are key inflammation-associated enzymes.
• Their co-expression is a significant prognostic indicator in triple-negative breast cancer (TNBC).
• These enzymes produce nitric oxide (NO) and prostaglandin E2 (PGE2), respectively, impacting tumor microenvironment.

Purpose of the Study:

• To review the role of NO and PGE2 in TNBC progression.
• To explore how NOS2 and COX2 shape tumor microenvironment communication.
• To understand their contribution to immune evasion and metastasis in TNBC.

Main Methods:

• Literature review of recent findings on NOS2, COX2, NO, and PGE2 in TNBC.
• Analysis of their roles in intercellular communication and immune system interaction.
• Examination of their impact on metabolic shifts and adaptation to hypoxia.

Main Results:

• NOS2 and COX2 co-expression is a strong prognostic marker in TNBC.
• NO and PGE2 signaling influences autocrine and paracrine communication within the tumor microenvironment.
• Dysregulated NOS2-COX2 activity contributes to metabolic reprogramming, immune suppression, and metastasis.

Conclusions:

• NOS2 and COX2 play critical roles in promoting TNBC progression and metastasis.
• Targeting NO and PGE2 pathways may offer therapeutic strategies for TNBC.
• Understanding the interplay between these enzymes and the tumor microenvironment is crucial for TNBC treatment.